308 related articles for article (PubMed ID: 6624354)
1. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
Nekipelov EF; Serbinenko FA
Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
[TBL] [Abstract][Full Text] [Related]
2. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome].
Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K
Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
Strother CM; Newton TH
Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
[TBL] [Abstract][Full Text] [Related]
4. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
5. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
[TBL] [Abstract][Full Text] [Related]
6. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
Trojanowski P; Jargiello T; Trojanowska A; Klatka J
Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
[TBL] [Abstract][Full Text] [Related]
7. Osler-Weber-Rendu syndrome.
Mani BI; Rubel AR; Chauhdary WA; Bashir A; Soe ZN; Javed N; Sharif SMA; Hla Aye MT; Chong VH
QJM; 2020 Aug; 113(8):586-587. PubMed ID: 32170936
[No Abstract] [Full Text] [Related]
8. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
Weissman JL; Jungreis CA; Johnson JT
Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
[TBL] [Abstract][Full Text] [Related]
9. [Critical evaluation of vascular embolization in patients with Rendu-Osler disease].
Fischer M; Dietrich U; Labisch C; Zanella FE; Jahnke K
Laryngorhinootologie; 1997 Aug; 76(8):490-4. PubMed ID: 9376033
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous therapeutic embolization in therapy refractory, non-traumatic epistaxis].
Kramann B; Roth R; Schneider G; Uder M; Federspil P; Iro H
HNO; 1998 Dec; 46(12):973-9. PubMed ID: 10023591
[TBL] [Abstract][Full Text] [Related]
11. [Epistaxis-overview and current aspects].
Thangavelu K; Köhnlein S; Eivazi B; Gurschi M; Stuck BA; Geisthoff U
HNO; 2021 Nov; 69(11):931-942. PubMed ID: 34643746
[TBL] [Abstract][Full Text] [Related]
12. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
[TBL] [Abstract][Full Text] [Related]
13. Treatment of a nasal vascular malformation in a patient with Osler-Weber-Rendu syndrome via percutaneous N-butyl 2-cyanoacrylate embolization: case report and review of the literature.
Chowdhry SA; Ponsky DC; Hsu DP
J Otolaryngol Head Neck Surg; 2011 Apr; 40(2):E11-4. PubMed ID: 21453641
[No Abstract] [Full Text] [Related]
14. [Rendu-Osler-Weber disease. Diagnostic and therapeutic assessment by angiography].
Lasjaunias P; Appel B; Carrière T
Ann Otolaryngol Chir Cervicofac; 1983; 100(3):203-15. PubMed ID: 6870092
[TBL] [Abstract][Full Text] [Related]
15. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
16. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
[TBL] [Abstract][Full Text] [Related]
18. Letter: Rendu-Osler-Weber disease--is embolization beneficial?
Weisberg JJ
Arch Otolaryngol; 1976 Jun; 102(6):385. PubMed ID: 1275812
[No Abstract] [Full Text] [Related]
19. [Our experience on Rendu-Osler disease. Apropos of 19 cases].
Seidermann L; Mérol JC; Nasser T; Swierkosz F; Legros M
Rev Laryngol Otol Rhinol (Bord); 1996; 117(5):367-72. PubMed ID: 9183908
[TBL] [Abstract][Full Text] [Related]
20. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]